Elena Viboch is a Managing Director at General Catalyst, where she invests in Seed through Series C stage companies across healthcare, life sciences, biotech, and health technology in North America, the United States, and Europe. She has invested in companies including Paradigm, Odyssey Therapeutics, Dewpoint Therapeutics, Eikon, and Alpha-9 Oncology. Previously, she was an Investment Director at SoftBank Investment Advisers and held corporate development and operating roles at NanoString Technologies, Carmot Therapeutics, FLX Bio, Jazz Pharmaceuticals, and Kearny Venture Partners; earlier, she was a consultant at Putnam Associates. Elena graduated from Harvard Business School and resides in San Francisco, California.
Elena Viboch, Managing Director @ General Catalyst. Profile with intro opportunities and ranking information.